Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Profit After Tax (2016 - 2025)

Rockwell Medical's Profit After Tax history spans 16 years, with the latest figure at -$554000.0 for Q4 2025.

  • For Q4 2025, Profit After Tax rose 26.72% year-over-year to -$554000.0; the TTM value through Dec 2025 reached -$5.3 million, down 1007.08%, while the annual FY2025 figure was -$5.3 million, 1007.08% down from the prior year.
  • Profit After Tax reached -$554000.0 in Q4 2025 per RMTI's latest filing, up from -$1.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $1.7 million in Q3 2024 to a low of -$8.9 million in Q4 2021.
  • Average Profit After Tax over 5 years is -$3.3 million, with a median of -$1.8 million recorded in 2023.
  • Peak YoY movement for Profit After Tax: soared 188.89% in 2024, then crashed 534.99% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$8.9 million in 2021, then soared by 73.58% to -$2.4 million in 2022, then surged by 35.99% to -$1.5 million in 2023, then soared by 50.0% to -$756000.0 in 2024, then increased by 26.72% to -$554000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Profit After Tax are -$554000.0 (Q4 2025), -$1.8 million (Q3 2025), and -$1.5 million (Q2 2025).